If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Board Changes

Today 07:00

RNS Number : 2289L
Transense Technologies PLC
07 July 2026
 

7 July 2026

Transense Technologies plc

("Transense" or the "Company")

Board Changes

Retirement of Chief Financial Officer and Appointment of Finance Director (designate)

Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement solutions, announces that Melvyn Segal has informed the Board of his intention to retire from the role of Chief Financial Officer ("CFO") and Company Secretary with effect from the Company's Annual General Meeting (AGM) in November 2026. The Board also announces the appointment of Richard Michael Pearce ACA as Finance Director with effect from 1 September 2026.

Melvyn will remain with the Company in an executive capacity for a handover period until the AGM, and will subsequently remain on the Board as a non-executive director for a further year. The Board would like to thank Melvyn for his significant contribution to Transense over many years, during which the Company and its prospects have been transformed.

Richard brings over twenty years of financial, commercial and listed company experience to Transense. Since qualifying as a Chartered Accountant with Ernst & Young in 1999, he has held senior finance roles at GE Healthcare and TD Williamson, and most recently as Finance Director at Lombard Medical where he oversaw a scale-up in revenues from £6m to £25m per annum since 2018. He will initially work alongside Melvyn in a non-board role as Finance Director, with progression to the Board leading the Group's finance function when Melvyn's steps down as CFO in November 2026.

The Board welcomes Richard to his new role and we look forward to his contribution to delivery of the future growth strategy.

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

· SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

· Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.

 In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

Find out more at: https://www.transense.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKABQCBKDDOK
Date   Source Headline
10th Jan 20071:45 pmRNSHolding(s) in Company
20th Dec 20067:01 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSRe Agreement
27th Nov 20067:01 amRNSRe Agreement
13th Nov 200612:18 pmRNSHolding(s) in Company
8th Nov 20063:35 pmRNSHolding(s) in Company
3rd Nov 20067:00 amRNSMichelin launches TPMS
1st Nov 20065:31 pmRNSHolding(s) in Company
31st Oct 20064:23 pmRNSHolding(s) in Company
30th Oct 20069:40 amRNSStatement re Press Comment
19th Oct 20064:19 pmRNSHolding(s) in Company
22nd Sep 20067:01 amRNSInterim Results
22nd Sep 20067:01 amRNSAgreement with Lear Corp.
22nd Sep 20067:01 amRNSHolding(s) in Company
18th Sep 200612:02 pmRNSHolding(s) in Company
15th Sep 20062:23 pmRNSHolding(s) in Company
7th Jul 20064:44 pmRNSHolding(s) in Company
6th Jul 20067:01 amRNSRe Agreement
13th Jun 200612:24 pmRNSHolding(s) in Company
13th Jun 200612:23 pmRNSHolding(s) in Company
19th May 20067:01 amRNSAGM Statement
21st Apr 20064:49 pmRNSHolding(s) in Company
10th Apr 200611:02 amRNSDirector/PDMR Shareholding
5th Apr 20063:26 pmRNSHolding(s) in Company
31st Mar 20067:01 amRNSFinal Results
13th Mar 20064:39 pmRNSHolding(s) in Company
20th Dec 20054:59 pmRNSHolding(s) in Company
21st Nov 20054:28 pmRNSDirectorate Change
6th Oct 20053:00 pmRNSIssue of Equity
29th Sep 20057:01 amRNSInterim Results
31st Aug 20052:45 pmRNSDirector Shareholding
17th Aug 200510:03 amRNSHolding(s) in Company
25th Jul 20053:35 pmRNSDirector Shareholding
20th May 200512:05 pmRNSAGM Statement
12th Apr 20052:47 pmRNSDirector Shareholding
8th Apr 20057:00 amRNSRe Agreement
6th Apr 20055:23 pmRNSHolding(s) in Company
6th Apr 20054:36 pmRNSSAR - Transense Technlgy
6th Apr 20053:50 pmRNSDirector Shareholding
6th Apr 20053:39 pmRNSHolding(s) in Company
22nd Mar 20057:01 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.